Effect of cyclosporine on endothelial albumin leakage in rats

Leon C. Moore, June Mason, Leonard Feld, Judith B. Van Liew, Frederick J. Kaskel

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Short-term treatment of rats with cyclosporine (cyclosporine A (CsA); Sandimmune®) results in a marked reduction in intravascular plasma volume, a factor that might contribute to the renal dysfunction associated with this potent immunosuppressant. To examine the role of plasma extravasation in CsA-induced hypovolemia, intravascular plasma volumes (PV), blood volumes, (125I)albumin disappearance, and changes in hematocrit (Hct) were measured in Inactin-anesthetized rats subjected to minimal surgery. The rats were treated for 3 wk with either 25 mg/kg/day of CsA s.c. or vehicle. Plasma creatinine and urea were significantly elevated, and magnesium was reduced in the CsA group (N = 6) as compared with controls (CON) (N = 6). CsA treatment had no effect on urinary protein and albumin excretion. Blood volume was significantly lower in CsA than in CON (8.4 ± 0.5 versus 10.6 ± 0.3 mL/100 g body wt) as was PV (4.3 ± 0.2 versus 5.5 ± 0.2 mL/100 g body wt). Two hours after injection, plasma (125I)albumin concentration had fallen by 41 ± 4% in CsA versus 23 ± 5% in CON. Because Hct, and, hence PV, was unchanged in both groups during these 2 h, these data indicate enhanced endothelial albumin leakage in the CsA group. In two additional groups of six rats each, acute volume expansion with fresh whole blood (2 mL/100 g body wt) resulted in extravasation of plasma. Hct rose by 8.0 ± 0.2% in CsA versus 3.8 ± 0.2% in CON after 150 min, corresponding to 27 ± 3 and 15 ± 2% decreases in total PV, respectively. Similar bulk losses of plasma were observed after the infusion of an identical volume of fresh plasma. Hence, CsA impairs the ability of the endothelium to retain plasma protein and fluid within the circulation, an effect that will contribute to the prerenal azotemia seen in CsA-treated rats and humans.

Original languageEnglish (US)
Pages (from-to)51-57
Number of pages7
JournalJournal of the American Society of Nephrology
Volume3
Issue number1
StatePublished - Jul 1992
Externally publishedYes

Fingerprint

Cyclosporine
Albumins
Plasma Volume
Hematocrit
Blood Volume
Azotemia
Hypovolemia
Immunosuppressive Agents
Serum Albumin
Magnesium
Endothelium
Urea
Blood Proteins
Creatinine
Kidney
Injections

Keywords

  • Albumin leakage
  • Blood volume
  • Cyclosporine
  • Endothelium
  • Plasma volume
  • Rats

ASJC Scopus subject areas

  • Nephrology

Cite this

Effect of cyclosporine on endothelial albumin leakage in rats. / Moore, Leon C.; Mason, June; Feld, Leonard; Van Liew, Judith B.; Kaskel, Frederick J.

In: Journal of the American Society of Nephrology, Vol. 3, No. 1, 07.1992, p. 51-57.

Research output: Contribution to journalArticle

Moore, LC, Mason, J, Feld, L, Van Liew, JB & Kaskel, FJ 1992, 'Effect of cyclosporine on endothelial albumin leakage in rats', Journal of the American Society of Nephrology, vol. 3, no. 1, pp. 51-57.
Moore, Leon C. ; Mason, June ; Feld, Leonard ; Van Liew, Judith B. ; Kaskel, Frederick J. / Effect of cyclosporine on endothelial albumin leakage in rats. In: Journal of the American Society of Nephrology. 1992 ; Vol. 3, No. 1. pp. 51-57.
@article{4b5333d11f404091a9667d63b8c1720e,
title = "Effect of cyclosporine on endothelial albumin leakage in rats",
abstract = "Short-term treatment of rats with cyclosporine (cyclosporine A (CsA); Sandimmune{\circledR}) results in a marked reduction in intravascular plasma volume, a factor that might contribute to the renal dysfunction associated with this potent immunosuppressant. To examine the role of plasma extravasation in CsA-induced hypovolemia, intravascular plasma volumes (PV), blood volumes, (125I)albumin disappearance, and changes in hematocrit (Hct) were measured in Inactin-anesthetized rats subjected to minimal surgery. The rats were treated for 3 wk with either 25 mg/kg/day of CsA s.c. or vehicle. Plasma creatinine and urea were significantly elevated, and magnesium was reduced in the CsA group (N = 6) as compared with controls (CON) (N = 6). CsA treatment had no effect on urinary protein and albumin excretion. Blood volume was significantly lower in CsA than in CON (8.4 ± 0.5 versus 10.6 ± 0.3 mL/100 g body wt) as was PV (4.3 ± 0.2 versus 5.5 ± 0.2 mL/100 g body wt). Two hours after injection, plasma (125I)albumin concentration had fallen by 41 ± 4{\%} in CsA versus 23 ± 5{\%} in CON. Because Hct, and, hence PV, was unchanged in both groups during these 2 h, these data indicate enhanced endothelial albumin leakage in the CsA group. In two additional groups of six rats each, acute volume expansion with fresh whole blood (2 mL/100 g body wt) resulted in extravasation of plasma. Hct rose by 8.0 ± 0.2{\%} in CsA versus 3.8 ± 0.2{\%} in CON after 150 min, corresponding to 27 ± 3 and 15 ± 2{\%} decreases in total PV, respectively. Similar bulk losses of plasma were observed after the infusion of an identical volume of fresh plasma. Hence, CsA impairs the ability of the endothelium to retain plasma protein and fluid within the circulation, an effect that will contribute to the prerenal azotemia seen in CsA-treated rats and humans.",
keywords = "Albumin leakage, Blood volume, Cyclosporine, Endothelium, Plasma volume, Rats",
author = "Moore, {Leon C.} and June Mason and Leonard Feld and {Van Liew}, {Judith B.} and Kaskel, {Frederick J.}",
year = "1992",
month = "7",
language = "English (US)",
volume = "3",
pages = "51--57",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "1",

}

TY - JOUR

T1 - Effect of cyclosporine on endothelial albumin leakage in rats

AU - Moore, Leon C.

AU - Mason, June

AU - Feld, Leonard

AU - Van Liew, Judith B.

AU - Kaskel, Frederick J.

PY - 1992/7

Y1 - 1992/7

N2 - Short-term treatment of rats with cyclosporine (cyclosporine A (CsA); Sandimmune®) results in a marked reduction in intravascular plasma volume, a factor that might contribute to the renal dysfunction associated with this potent immunosuppressant. To examine the role of plasma extravasation in CsA-induced hypovolemia, intravascular plasma volumes (PV), blood volumes, (125I)albumin disappearance, and changes in hematocrit (Hct) were measured in Inactin-anesthetized rats subjected to minimal surgery. The rats were treated for 3 wk with either 25 mg/kg/day of CsA s.c. or vehicle. Plasma creatinine and urea were significantly elevated, and magnesium was reduced in the CsA group (N = 6) as compared with controls (CON) (N = 6). CsA treatment had no effect on urinary protein and albumin excretion. Blood volume was significantly lower in CsA than in CON (8.4 ± 0.5 versus 10.6 ± 0.3 mL/100 g body wt) as was PV (4.3 ± 0.2 versus 5.5 ± 0.2 mL/100 g body wt). Two hours after injection, plasma (125I)albumin concentration had fallen by 41 ± 4% in CsA versus 23 ± 5% in CON. Because Hct, and, hence PV, was unchanged in both groups during these 2 h, these data indicate enhanced endothelial albumin leakage in the CsA group. In two additional groups of six rats each, acute volume expansion with fresh whole blood (2 mL/100 g body wt) resulted in extravasation of plasma. Hct rose by 8.0 ± 0.2% in CsA versus 3.8 ± 0.2% in CON after 150 min, corresponding to 27 ± 3 and 15 ± 2% decreases in total PV, respectively. Similar bulk losses of plasma were observed after the infusion of an identical volume of fresh plasma. Hence, CsA impairs the ability of the endothelium to retain plasma protein and fluid within the circulation, an effect that will contribute to the prerenal azotemia seen in CsA-treated rats and humans.

AB - Short-term treatment of rats with cyclosporine (cyclosporine A (CsA); Sandimmune®) results in a marked reduction in intravascular plasma volume, a factor that might contribute to the renal dysfunction associated with this potent immunosuppressant. To examine the role of plasma extravasation in CsA-induced hypovolemia, intravascular plasma volumes (PV), blood volumes, (125I)albumin disappearance, and changes in hematocrit (Hct) were measured in Inactin-anesthetized rats subjected to minimal surgery. The rats were treated for 3 wk with either 25 mg/kg/day of CsA s.c. or vehicle. Plasma creatinine and urea were significantly elevated, and magnesium was reduced in the CsA group (N = 6) as compared with controls (CON) (N = 6). CsA treatment had no effect on urinary protein and albumin excretion. Blood volume was significantly lower in CsA than in CON (8.4 ± 0.5 versus 10.6 ± 0.3 mL/100 g body wt) as was PV (4.3 ± 0.2 versus 5.5 ± 0.2 mL/100 g body wt). Two hours after injection, plasma (125I)albumin concentration had fallen by 41 ± 4% in CsA versus 23 ± 5% in CON. Because Hct, and, hence PV, was unchanged in both groups during these 2 h, these data indicate enhanced endothelial albumin leakage in the CsA group. In two additional groups of six rats each, acute volume expansion with fresh whole blood (2 mL/100 g body wt) resulted in extravasation of plasma. Hct rose by 8.0 ± 0.2% in CsA versus 3.8 ± 0.2% in CON after 150 min, corresponding to 27 ± 3 and 15 ± 2% decreases in total PV, respectively. Similar bulk losses of plasma were observed after the infusion of an identical volume of fresh plasma. Hence, CsA impairs the ability of the endothelium to retain plasma protein and fluid within the circulation, an effect that will contribute to the prerenal azotemia seen in CsA-treated rats and humans.

KW - Albumin leakage

KW - Blood volume

KW - Cyclosporine

KW - Endothelium

KW - Plasma volume

KW - Rats

UR - http://www.scopus.com/inward/record.url?scp=0026889417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026889417&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 51

EP - 57

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 1

ER -